Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models

Journal of General Virology

Volumn 95, Issue PART 4, 2014, Pages 793-798

  Park, Su Jin ^a   Kim, Eun Ha ^a   Pascua, Philippe Noriel Q ^a   Kwon, Hyeok Il ^a   Lim, Gyo Jin ^a   Decano, Arun ^a   Kim, Se Mi ^a   Song, Man Ki ^b   Shin, Eui Cheol ^c   Choi, Young Ki ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b International Vaccine Institute   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CONTROLLED STUDY; DRUG EFFICACY; FERRET; IMMUNIZATION; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEROLOGY; TREATMENT OUTCOME;

ANIMALS; CROSS PROTECTION; DISEASE MODELS, ANIMAL; FERRETS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VACCINES, INACTIVATED; VIRAL LOAD;

EID: 84897096713     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.058636-0     Document Type: Article

References (27)

1. Air, G. M. (1981). Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus. Proc Natl Acad Sci U S A 78, 7639-7643.
2. Beigel, J. H., Farrar, J., Han, A. M., Hayden, F. G., Hyer, R., de Jong, M. D., Lochindarat, S., Nguyen, T. K., Nguyen, T. H. & other authors (2005). Avian influenza A (H5N1) infection in humans. N Engl J Med 353, 1374-1385.
3. Bodewes, R., Kreijtz, J. H., Baas, C., Geelhoed-Mieras, M. M., de Mutsert, G., van Amerongen, G., van den Brand, J. M., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2009). Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS ONE 4, e5538.
4. Bodewes, R., Kreijtz, J. H., Geelhoed-Mieras, M. M., van Amerongen, G., Verburgh, R. J., van Trierum, S. E., Kuiken, T., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2011). Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J Virol 85, 2695-2702.
5. Bragstad, K., Jørgensen, P. H., Handberg, K., Hammer, A. S., Kabell, S. & Fomsgaard, A. (2007). First introduction of highly pathogenic H5N1 avian influenza A viruses in wild and domestic birds in Denmark, Northern Europe. Virol J 4, 43.
6. Brewoo, J. N., Powell, T. D., Jones, J. C., Gundlach, N. A., Young, G. R., Chu, H., Das, S. C., Partidos, C. D., Stinchcomb, D. T. & Osorio, J. E. (2013). Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice. Vaccine 31, 1848-1855.
7. Cattoli, G., Monne, I., Fusaro, A., Joannis, T. M., Lombin, L. H., Aly, M. M., Arafa, A. S., Sturm-Ramirez, K. M., Couacy-Hymann, E. & other authors (2009). Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates. PLoS ONE 4, e4842.
8. Chen, Z., Kim, L., Subbarao, K. & Jin, H. (2012). The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that crossreact with the NA of H5N1 viruses in ferrets. Vaccine 30, 2516-2522.
9. Claas, E. C., Osterhaus, A. D., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F., Senne, D. A., Krauss, S., Shortridge, K. F. & Webster, R. G. (1998). Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351, 472-477.
10. He, X. S., Holmes, T. H., Zhang, C., Mahmood, K., Kemble, G. W., Lewis, D. B., Dekker, C. L., Greenberg, H. B. & Arvin, A. M. (2006). Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80, 11756-11766.
11. Heiny, A. T., Miotto, O., Srinivasan, K. N., Khan, A. M., Zhang, G. L., Brusic, V., Tan, T. W. & August, J. T. (2007). Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS ONE 2, e1190.
12. Hoft, D. F., Babusis, E., Worku, S., Spencer, C. T., Lottenbach, K., Truscott, S. M., Abate, G., Sakala, I. G., Edwards, K. M. & other authors (2011). Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 204, 845-853.
13. Kreijtz, J. H., de Mutsert, G., van Baalen, C. A., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2008). Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82, 5161-5166.
14. Kreijtz, J. H., Suezer, Y., de Mutsert, G., van den Brand, J. M., van Amerongen, G., Schnierle, B. S., Kuiken, T., Fouchier, R. A., Lower, J. & other authors (2009). Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses. Vaccine 27, 6296-6299.
15. Lamb, R. A., Zebedee, S. L. & Richardson, C. D. (1985). Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40, 627-633.
16. Lambert, L. C. & Fauci, A. S. (2010). Influenza vaccines for the future. N Engl J Med 363, 2036-2044.
17. Lee, L. Y., Ha, L. A., Simmons, C., de Jong, M. D., Chau, N. V., Schumacher, R., Peng, Y. C., McMichael, A. J., Farrar, J. J. & other authors (2008). Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118, 3478-3490.
18. Lee, B. J., Lee, S. H., Song, M. S., Pascua, P. N., Kwon, H. I., Park, S. J., Kim, E. H., Decano, A., Kim, S. M. & other authors (2013). Adjuvant efficacy of mOMV against avian influenza virus infection in mice. J Microbiol 51, 682-688.
19. + cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med 188, 223-232.
20. Nabel, G. J. & Fauci, A. S. (2010). Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine. Nat Med 16, 1389-1391.
21. Pappaioanou, M. (2009). Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic? Comp Immunol Microbiol Infect Dis 32, 287-300.
22. Sakabe, S., Iwatsuki-Horimoto, K., Horimoto, T., Nidom, C. A., Quynh Le, M., Takano, R., Kubota-Koketsu, R., Okuno, Y., Ozawa, M. Kawaoka, Y. (2010). A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Antiviral Res 88, 249-255.
23. Schulman, J. L. & Kilbourne, E. D. (1965). Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J Bacteriol 89, 170-174.
24. Tompkins, S. M., Zhao, Z. S., Lo, C. Y., Misplon, J. A., Liu, T., Ye, Z., Hogan, R. J., Wu, Z., Benton, K. A. & other authors (2007). Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 13, 426-435.
25. Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García-Sastre, A., Moran, T. M. & Palese, P. (2010). Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci USA 107, 18979-18984.
26. WHO (2013) Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. Geneva, Switzeland: WHO. http://www.who.int/influenza/human_animal_interface/EN_GIP_20131008CumulativeNumberH5N1cases.pdf
27. Yewdell, J. W., Bennink, J. R., Smith, G. L. & Moss, B. (1985). Influenza A virus nucleoprotein is a major target antigen for crossreactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 82, 1785-1789.